These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28061797)

  • 1. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.
    Angulo P; Kaushik G; Subramaniam D; Dandawate P; Neville K; Chastain K; Anant S
    J Hematol Oncol; 2017 Jan; 10(1):10. PubMed ID: 28061797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K/Akt signaling in osteosarcoma.
    Zhang J; Yu XH; Yan YG; Wang C; Wang WJ
    Clin Chim Acta; 2015 Apr; 444():182-92. PubMed ID: 25704303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
    Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
    Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Signaling Pathways as Potential Therapeutic Targets in Osteosarcoma.
    Dana PM; Sadoughi F; Asemi Z; Yousefi B
    Curr Med Chem; 2022; 29(25):4436-4444. PubMed ID: 35139778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-calculating! Navigating through the osteosarcoma treatment roadblock.
    McGuire J; Utset-Ward TJ; Reed DR; Lynch CC
    Pharmacol Res; 2017 Mar; 117():54-64. PubMed ID: 27940205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma: review of the past, impact on the future. The American experience.
    Jaffe N
    Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to explore new approaches in the investigation and treatment of osteosarcoma.
    Kim SY; Helman LJ
    Cancer Treat Res; 2009; 152():517-28. PubMed ID: 20213413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering signaling networks in osteosarcoma pathobiology.
    Adamopoulos C; Gargalionis AN; Basdra EK; Papavassiliou AG
    Exp Biol Med (Maywood); 2016 Jun; 241(12):1296-305. PubMed ID: 27190271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
    Zhang W; Li Q; Song C; Lao L
    Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway.
    Wang H; Sun N; Li X; Li K; Tian J; Li J
    Oncol Rep; 2016 Jun; 35(6):3648-58. PubMed ID: 27035545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
    Hughes DP
    Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of osteogenic sarcoma.
    Wang LL
    Cancer J; 2005; 11(4):294-305. PubMed ID: 16197719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
    Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
    Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
    Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
    J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
    Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
    Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.
    Zahedipour F; Bolourinezhad M; Teng Y; Sahebkar A
    J Oncol; 2021; 2021():3006853. PubMed ID: 34671398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.